M.D. Duygu Sezen

M.D. Duygu Sezen
Country:
City:
Department:
Experience: 5 years of experience
Hospital: KOC University Hospital, Istanbul

About

About M.D. Duygu Sezen M.D. Duygu Sezen is a well-experienced Radiation Oncologist at Koc University Hospital, Turkey since June 2014.  M.D. Duygu Sezen graduated from Gazi University Faculty of Medicine in 2005.  In 2011, M.D. Duygu Sezen completed her Radiation Oncology residency training at Hacettepe University School of Medicine. M.D. Duygu Sezen completed her obligatory service at Radiation Oncology Department in Erzurum Regional Training and Research Hospital between 2011-2014.  M.D. Duygu Sezen has also worked with St.James’s University Hospital in Leeds, UK and MD Anderson Cancer Center in Houston, USA as an observer.

List of Treatments

  • Metastatic Tumors Treatment
  • Chemotherapy
  • Radiotherapy
  • Adrenal Cancer Treatment
  • Anal Cancer Treatment
  • Bile Duct Cancer Treatment
  • Bladder Cancer Treatment
  • Bone Cancer Treatment
  • Breast Cancer-Surgical
  • Cancer in Children
  • Carcinoma of Unknown Primary (CUP) Treatment
  • Castleman Disease Treatment
  • Cervical Cancer Treatment
  • Endometrial Cancer Treatment
  • Esophagus Cancer Treatment
  • Ewing Family of Tumors Treatment
  • Eye Cancer Treatment
  • Gallbladder Cancer Treatment
  • Carcinoid Tumors Treatment
  • Gastrointestinal Stromal Tumor GIST Treatment
  • Gestational Trophoblastic Disease (GTD) Treatment
  • Hodgkin Disease Treatment
  • Kaposi Sarcoma Treatment
  • Kidney Cancer Treatment
  • Laryngeal and Hypopharyngeal Cancer Treatment
  • Acute Lymphocytic Leukemia – ALL in Adults
  • Leukemia – Acute Myeloid AML
  • Chronic Lymphocytic Leukemia – CLL
  • Chronic Myeloid Leukemia- CML
  • Chronic Myelomonocytic Leukemia – CMML
  • Leukemia in Children
  • Liver Cancer
  • Lung Cancer Treatment
  • Non-Small Cell Lung Cancer (NSCLC) Treatment
  • Small-cell Carcinoma Treatment
  • Lung Carcinoid Tumor Treatment
  • Skin Lymphoma Treatment
  • Malignant Mesothelioma Treatment
  • Multiple Myeloma Treatment
  • Nasal Cavity and Paranasal Sinus Cancer Treatment
  • Nasopharyngeal Cancer Treatment
  • Neuroblastoma
  • Non-Hodgkin Lymphoma (NHL) Treatment
  • Non-Hodgkin Lymphoma In Children
  • Oral Cavity and Oropharyngeal Cancer
  • Osteosarcoma (OS) Treatment
  • Ovarian Cancer Surgery
  • Pancreatic Cancer
  • Penile Cancer Treatment
  • Prostate Cancer-Surgical
  • Retinoblastoma (RB) Treatment
  • Rhabdomyosarcoma (RMS) Treatment
  • Salivary Gland Cancer
  • Soft Tissue Sarcoma Treatment
  • Skin Cancer
  • Basal Cell and Squamous Cell Carcinoma
  • Skin Cancer – Melanoma
  • Small Intestine Cancer Treatment
  • Stomach Cancer Treatment
  • Testicular Cancer Treatment
  • Thymoma and Thymic Carcinoma Treatment
  • Thyroid Cancer Treatment
  • Uterine Sarcoma
  • Vaginal Cancer Treatment
  • Vulvar Cancer Treatment
  • Waldenstrom Macroglobulinemia
  • Wilms Tumor (Nephroblastoma)
  • Breast Biopsy
  • Autologous Stem Cell Transplant for Lymphoma
  • Pediatric Bone Marrow Transplant
  • Oral Cancer – Surgical
  • Breast Cancer
  • Leukemia Treatment
  • Hairy Cell Leukemia – HCL
  • Fallopian Tube Cancer
  • Ovarian Germ Cell Tumor
  • Ovarian Primary Peritoneal Cancer
  • Medullary Carcinoma
  • Papillary Thyroid Cancer Treatment
  • Bone Marrow Cancer
  • Ovarian Sex Cord Stromal Tumor
  • Invasive Lobular Carcinoma
  • Colon Cancer Treatment
  • Cancer Treatment
  • Adenocarcinoma – Glandular Cancer Treatment
  • Immunotherapy
  • Breast Conservation Surgery – BCS
  • Breast Lumpectomy
  • IMRT

Work Experience

, Erzurum Regional Training and Research Hospital

, St.James’s University Hospital in Leeds, UK

, MD Anderson Cancer Center in Houston, USA

, KOC University Hospital, Istanbul

Special Interest

Targeted Therapy,
Immunotherapy